Bank of America
GENE

Bank of America’s Genetic Technologies Ltd. GENE Stock Holding History

Bank of America’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50
Closed – – 8508
2022
Q3 		$0 Buy
+50
New +$365 ﹤0.01% 8319
2019
Q3 		– Hold
0
– – – 7580
2019
Q2 		– Hold
0
– – – 7476
2017
Q4 		– Sell
-3,036
Closed -$52K – 7312
2017
Q3 		$52K Buy
3,036
+22
+0.7% +$367 ﹤0.01% 5928
2017
Q2 		$54K Buy
+3,014
New +$63.1K ﹤0.01% 5846
2017
Q1 		– Sell
-2
Closed – – 7298
2016
Q4 		$0 Buy
+2
New +$55 ﹤0.01% 7390
2015
Q4 		– Hold
0
– – – 7526
2015
Q3 		– Hold
0
– – – 7464
2015
Q2 		– Sell
-18
Closed -$2K – 7457
2015
Q1 		$2K Buy
+18
New +$1.47K ﹤0.01% 6714

Other funds holding GENE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Bank of America's GENE Position: Q4 2022 in Review

Bank of America sold out of Genetic Technologies Ltd. (GENE) in Q4 2022, closing a stake of 50 shares.

Bank of America first reported a position in GENE in Q1 2015 and held it in 5 quarters. The position peaked at $54K in Q2 2017. 8 funds tracked by Wall St. Rank hold GENE as of Q4 2022.

  • Bank of America reported no remaining Genetic Technologies Ltd. position as of Q4 2022 after selling out during the quarter.
  • Bank of America sold 50 Genetic Technologies Ltd. shares in Q4 2022.
  • Bank of America first reported a position in Genetic Technologies Ltd. in Q1 2015 and held it in 5 quarters.
  • Bank of America's Genetic Technologies Ltd. position peaked at $54K in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.